Back to search

Article

The ProBio Trial: Molecular Biomarkers for Advancing Personalized Treatment Decision in Patients with Metastatic Castration-Resistant Prostate Cancer

2020-05-18

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Multiple therapies exist for patients with metastatic castration-resistant prostate cancer (mCRPC). However, their improvement on progression free survival (PFS) remains modest, potentially explained by tumour molecular heterogeneity. Several prognostic molecular biomarkers have been identified for mCRPC that may have predictive potential to guide treatment sele...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c7b94644-7e63-527d-984a-d6ba26f9cc8e
DOI
10.21203/rs.2.23901/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The ProBio Trial: Molecular Biomarkers for Advancing Personalized Treatment Decision in Patients with Metastatic Castration-Resistant Prostate CancerDOI 10.21203/rs.2.23901/v2
[Molecular diagnostics and molecular tumor board in uro-oncology : Precision medicine using the example of metastatic castration-resistant prostate cancer].Semantic proximity
A predictive model of overall survival in patients with metastatic castration-resistant prostate cancerSemantic proximity
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.Semantic proximity
Comparison of Real-World Outcomes between Patients with BRCA1/2-Positive and Homologous Recombination Repair-Negative Metastatic Castration-Sensitive Prostate CancerSemantic proximity
Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancersSemantic proximity
Real-world insights from comprehensive genomic profiling in patients with metastatic castration-resistant prostate cancer.Semantic proximity
Olaparib in Patients With Metastatic Prostate Cancer With BRCA1/2 Mutation: Results From the TAPUR Study.Semantic proximity
An 18-Gene Algorithm urine test for predicting prostate cancer metastasis and castration- resistanceSemantic proximity
Additive Clinical Utility of Microsatellite Instability and Tumor Mutational Burden to Predict Immune Checkpoint Inhibitor Effectiveness in Metastatic Castration-Resistant Prostate Cancer.Semantic proximity
Survival prognosis and variable selection: A case study for metastatic castrate resistant prostate cancer patientsSemantic proximity
VALIDATION OF PROGRESS, A SIMPLE MACHINE-LEARNING DERIVED RISK STRATIFICATION SCORE FOR CASTRATION-RESISTANT PROSTATE CANCERSemantic proximity
SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer.Semantic proximity
Select a neighboring publication to make it the new centre.